Nasdaq warns Gossamer Bio (NASDAQ: GOSS) over sub-$1 share price
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Gossamer Bio, Inc. received a notice from Nasdaq that its common stock failed to meet the $1.00 minimum bid price requirement for 30 consecutive business days from February 24 through April 7, 2026. This puts its listing on the Nasdaq Global Select Market at risk.
The company has 180 days, until October 5, 2026, to regain compliance by having its closing bid at or above $1.00 for at least ten consecutive business days. If it still does not comply, it may seek an additional 180-day period by transferring to the Nasdaq Capital Market and potentially taking actions such as a reverse stock split. The company plans to monitor its share price and evaluate options, but there is no assurance it will maintain its Nasdaq listing.
Positive
- None.
Negative
- Nasdaq bid-price deficiency and delisting risk: Gossamer Bio’s shares traded below the $1.00 minimum bid for 30 consecutive business days, triggering a Nasdaq notice and starting a 180-day window before potential delisting or forced actions such as a market transfer or reverse split.
Insights
Nasdaq bid-price deficiency heightens listing risk for Gossamer Bio.
Gossamer Bio has fallen below Nasdaq’s $1.00 minimum bid price for 30 consecutive business days, triggering a formal deficiency notice. The company now faces a defined compliance window with clear quantitative hurdles tied to its share price performance.
The firm has until October 5, 2026 to achieve a closing bid of at least $1.00 for ten consecutive business days. Failing that, it could seek another 180 days by moving to the Nasdaq Capital Market and meeting other listing standards, potentially using tools like a reverse stock split.
The notice introduces uncertainty around the company’s future exchange listing. Actual impact on shareholders will depend on whether the stock price recovers or whether actions such as a market transfer or reverse split are implemented and accepted by Nasdaq.
8-K Event Classification
Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
1 item
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Securities
The company received a delisting notice or transferred its listing to a different exchange.
Key Figures
Minimum bid price requirement: $1.00 per share
Deficiency measurement period: 30 consecutive business days
Initial compliance period: 180 calendar days
+2 more
5 metrics
Minimum bid price requirement
$1.00 per share
Nasdaq Listing Rule 5450(a)(1) minimum bid for continued listing
Deficiency measurement period
30 consecutive business days
From February 24, 2026 through April 7, 2026 below $1.00
Initial compliance period
180 calendar days
Until October 5, 2026 under Nasdaq Compliance Period Rule 5810(c)(3)(A)
Compliance trading requirement
10 consecutive business days
Closing bid at or above $1.00 before the Compliance Date
Potential additional compliance period
180 calendar days
Available if transferred to Nasdaq Capital Market and other standards met
Key Terms
Minimum Bid Price Requirement, Nasdaq Global Select Market, Compliance Period Rule, Nasdaq Capital Market, +2 more
6 terms
Minimum Bid Price Requirement financial
"had not maintained a minimum bid price of $1.00 per share, required for continued listing..."
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
Nasdaq Global Select Market financial
"required for continued listing on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1)"
A Nasdaq Global Select Market listing is the highest tier of stocks on the Nasdaq exchange, reserved for companies that meet the strictest financial, reporting and governance standards. For investors, it acts like a premium quality label—signaling larger, more transparent and better-governed companies that tend to offer greater liquidity and lower perceived risk compared with lower-tier listings, making it easier to buy, sell and evaluate shares.
Compliance Period Rule regulatory
"In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”)"
Nasdaq Capital Market financial
"the Company would be required to transfer its listing to the Nasdaq Capital Market and meet the continued listing requirement"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
reverse stock split financial
"such as by effecting a reverse stock split, if necessary"
A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.
delisting regulatory
"its Common Stock will be subject to delisting. At that time, the Company may appeal"
Delisting occurs when a company's stock is removed from a stock exchange and is no longer available for trading there. This can happen voluntarily or because the company no longer meets the exchange's requirements. For investors, delisting means they can no longer buy or sell shares of that company on the exchange, which may make it more difficult to sell their investments or affect the stock's value.
FAQ
What Nasdaq notice did Gossamer Bio (GOSS) receive about its stock?
Gossamer Bio received a Nasdaq notice that its common stock failed to maintain the required $1.00 minimum bid price for 30 consecutive business days. This deficiency places its Nasdaq Global Select Market listing at risk if compliance is not regained within the allowed period.
How long does Gossamer Bio (GOSS) have to regain Nasdaq bid-price compliance?
Gossamer Bio has 180 calendar days, until October 5, 2026, to regain compliance. Its stock must close at or above $1.00 per share for at least ten consecutive business days within this period to satisfy Nasdaq’s minimum bid price requirement.
What happens if Gossamer Bio (GOSS) does not meet the $1.00 bid requirement by October 5, 2026?
If Gossamer Bio does not regain compliance by October 5, 2026, it may qualify for another 180-day period by transferring to the Nasdaq Capital Market, meeting that market’s listing standards, and formally notifying Nasdaq of its plan to cure the deficiency.
Could Gossamer Bio (GOSS) be delisted from Nasdaq because of this notice?
Yes. If Gossamer Bio ultimately cannot meet Nasdaq listing standards, the Staff may notify the company that its common stock is subject to delisting. The company would then have the right to appeal to a Nasdaq Hearing Panel, but success is not assured.
What options might Gossamer Bio (GOSS) consider to regain Nasdaq compliance?
The company intends to monitor its closing bid price and may consider options such as a reverse stock split to raise its per-share price. Any such actions would aim to meet the minimum bid requirement but are not guaranteed to succeed.
Does Nasdaq’s minimum bid price notice immediately remove Gossamer Bio (GOSS) from listing?
No. The notice does not immediately delist Gossamer Bio’s shares from the Nasdaq Global Select Market. Instead, it starts a defined compliance period, during which the company can attempt to restore its stock price to required levels.